How Pelosi’s impeachment inquiry into Trump could be a plus for one stock sector

As the move to impeach President Donald Trump moves forward, one analyst contends that the proceedings could essentially bring Congress to even more of a screeching halt, notably on a bill that would curb some drug prices from pharmaceutical companies.